Behçet syndrome: Disease of the silk route
DOI:
https://doi.org/10.18041/2390-0512/biociencias.1.7843Keywords:
Behcet Syndrome, Recurrent oral aphtous, Complex aphtous, VasculitisAbstract
Behect`s disease is a variable vessel multysistemic vasculitic inflamatory disorder characterized by recurrent oral, genital, aphtous ulcers, posterior bilateral panuveitis, joint manifestations and occasionally compromiso of the central nervous system and large vessels. The varied clinical mmanifestations and the lack of pathognomonic test make the disease a diagnostic challenge whose prevalence in Colombia is unknown. The diagnosis is bases on diagnostic criterio proposed in absence of a Gold Estandard test. Regarding the etiology, varios theories have been studied incluiding those of inmunological origin especially due to the existence of HLA-B51, followed by those that blame infectious agents,endotelial damage among others. A case is presented, corresponding to a famale patient of 35 years og age with chronic and recurrent symptoms of oral trush, the presence of dermatological lesions and the appearance of genital ulcers is presented. Discarding inmunomediated, infectious and inflammatory causes. Considering a picture of recurrent bipolar aphtosis and faced with dermatológical symptoms, it vas proposes to apply the diagnostic criterio of the International Team for the Revision of the Internacional Criteria for Behcet Disease with a score of 4, which supports the diagnosis of Behcets disease. Management was based on the introduction of therapeutic measures bases on systemic corticosteroids and immunosuppressants, with an adequate clinical reponse.
Downloads
References
Gül A. Behçet disease. En: Hochberg MD, MPH, MACP, MACR MC, Gravallese MD EM, Silman MD, FRCP, FMedSci AJ, Smolen MD, FRCP JS, Weinblatt MD, FRCP, MACR ME, Weisman MD MH, editores. 2019. p. 1395–400. Disponible en: https://www.clinicalkey.es/#!/content/3-s2.0-B9780702068652001676
Kuzu MA, Özaslan C, Köksoy C, Gürler A, Tüzüner A. Vascular involvement in Behçet’s isease: 8-Year audit. World J Surg. noviembre de 1994;18(6):948–53.
Mutlu S, Scully C. The person behind the eponym: Hulûsi Behcet (1889‐1948). J Oral Pathol Med. 1994;23(7):289–90.
Cheng TO, Tirilomis T. Behçet disease, Adamantiades-Behçet disease, or Hippocrates-Adamantiades-Behçet disease? [2] (multiple letters). Vol. 122, Chest. American College of Chest Physicians; 2002. p. 381–2.
Davatchi F, Chams-Davatchi C, Shams H, Shahram F, Nadji A, Akhlaghi M, et al. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Vol. 13, Expert Review of Clinical Immunology. Taylor and Francis Ltd; 2017. p. 57–65.
Kurokawa MS, Suzuki N. Behcet’s disease. Vol. 4, Clinical and Experimental Medicine. Clin Exp Med; 2004. p. 10–20.
L. Vaillant, M. Samimi, D. Parent. Aftas, aftosis, enfermedad de Behçet. EMC – Dermatología. Vol. 50, numero 2, junio 2016. -
Cohen R, Metzger S, Nahir M, Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behçet’s disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis. 2002;61(2):157–60.
ohn S, Lee ES, Bang D, Lee S (1998). Síntomas parecidos a la enfermedad de Behcet inducidos por el virus del herpes simple en ratones ICR. Eur. J Dermatol 8: 21-23. -
O’Neill T, Rigby A, Silman A, Opthaimol CB-JJ, 1974 undefined. Behcet’s Disease Research Committee of Japan. Behcet’s disease: Guide to diagnosis of Behcet’s disease.
Davatchi F, Assaad-Khalil S, Calamia KT, Crook JE, Sadeghi-Abdollahi B, Schirmer M, et al. The International Criteria for Behçet’s Disease (ICBD): A collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatology Venereol. marzo de 2014;28(3):338–47.
Alpsoy E. New Evidence-Based Treatment Approach in Behçet Disease. Tursen Ü, Patholog Res; 2012:871019. Disponible en: https://doi.org/10.1155/2012/871019
Toro A M, Pinto L F, Velásquez C J, Márquez J D et al. Enfermedad de Behcet:.Experience in a Colombian cohort. Rev Colomb Reumatol. Vol. 16 No. 1, Marzo 2009, pp. 33-45.
Gabriel Riera Matute, Elena Riera Alonso. La aftosis oral recurrente en Reumatología. Reumatol Clin. 2011; 7323–328.
Davatchi F, Sadeghi Abdollahi B, et al. Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial. Mod Rheumatol 2009;19(5):542-9.
Hatemi G, Melikoglu M, Tunc R, et al. Apremilast for the treatment of Behçet’s disease: a phase II randomized, placebo-controlled, double-blind study. Arthritis Rheum 2013;65(Suppl 10):S322
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Biociencias

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
-
Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
-
NoComercial — No puede utilizar el material para una finalidad comercial.
-
CompartirIgual — Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
- No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.